Quarterly Report I 13/14
September 2013 – November 2013Diamyd Medical AB (publ), Fiscal year 2013/2014Reporting period September 1, 2013 – November 30, 2013 · Net sales amounted to MSEK 0.2 (0) · Loss before tax amounted to MSEK -4.8 ( profit 0.9) · Liquid assets and short term investments amounted to MSEK 61 (19) as of November 30, 2013 Significant events during the reporting period · Major owner increased holdings in Diamyd Medical Significant events after the reporting period · More than half of the patients treated in diabetes study with the diabetes vaccine Diamyd® · Diamyd
